Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology
Hypertrophic cardiomyopathy (HCM) is a heterogeneous group of heart muscle disorders that affects millions, with an incidence from 1 in 500 to 1 in 200. Factors such as genetics, age, gender, comorbidities, and environmental factors may contribute to the course of this disease. Diagnosis of HCM has...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2024-11-01
|
| Seri Bilgileri: | Biomedicines |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/2227-9059/12/12/2675 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|